wschnarr

/Wayne Schnarr

About Wayne Schnarr

This author has not yet filled in any details.
So far Wayne Schnarr has created 68 blog entries.

Big Pharma’s Drug War: Innovative vs. Generic and Biosimilar Drugs

By | February 16th, 2018|Beyond the Bench, Blog|

Big Pharma's Drug War: Innovative vs. Generic and Biosimilar Drugs [...]

Plasma for Profit: The Changing Landscape of Blood Donation

By | February 1st, 2018|Beyond the Bench, Blog|

Plasma for Profit: The Changing Landscape of Blood Donation By [...]

Q4 & Annual 2017 Share Price Performance – Part 3

By | January 25th, 2018|Analysis, Blog, Capital Markets|

            Tier 2 Canadian Healthcare [...]

Q4 & Annual 2017 Share Price Performance – Part 2

By | January 22nd, 2018|Analysis, Blog, Capital Markets|

              Tier 1 Canadian [...]

Q4 Share Price Performance in 2017 – Part 1

By | January 17th, 2018|Analysis, Blog, Capital Markets|

          Q4 and 12-Month 2017 Share [...]

The Emergence of the HIV/AIDS Epidemic and How it Affected the Human Plasma Industry

By | November 9th, 2017|Beyond the Bench, Blog|

The Emergence of the HIV/AIDS Epidemic and How it Affected [...]

Q3 Share Price Performance in 2017 – Part 3

By | November 8th, 2017|Analysis, Blog, Capital Markets|

  Tier 2 Canadian Healthcare Companies: Moderately Negative with Usual [...]

Q3 Share Price Performance in 2017 – Part 2

By | November 8th, 2017|Analysis, Blog, Capital Markets|

  Tier 1 Canadian Healthcare Companies: Mixed and Volatile Performance [...]

Q3 Share Price Performance in 2017 – Part 1

By | November 8th, 2017|Analysis, Blog, Capital Markets|

Very High Volatility and Mixed Performance The key statistic from [...]

Manufacturing Management and Technology Transfer in China

By | October 5th, 2017|Beyond the Bench, Blog|

Manufacturing Management and Technology Transfer in China By Wayne Schnarr [...]